Skip to main content

CORRECTION article

Front. Genet., 11 August 2023
Sec. Epigenomics and Epigenetics
Volume 14 - 2023 | https://doi.org/10.3389/fgene.2023.1265506
This article is part of the Research Topic Epigenetic Mechanisms and Their Involvement in Rare Diseases, Volume II View all 6 articles

Corrigendum: Role and mechanism of DNA methylation and its inhibitors in hepatic fibrosis

This article is a correction to:

  1. Role and mechanism of DNA methylation and its inhibitors in hepatic fibrosis

    1. Read original article
Shi-Yi Lyu&#x;Shi-Yi Lyu1†Wang Xiao&#x;Wang Xiao2†Guang-Zu CuiGuang-Zu Cui3Cheng YuCheng Yu1Huan LiuHuan Liu1Min LyuMin Lyu1Qian-Ya KuangQian-Ya Kuang1En-Hua XiaoEn-Hua Xiao1Yong-Heng Luo Yong-Heng Luo1*
  • 1Department of Radiology, The Second Xiangya Hospital, Central-South University, Changsha, Hunan, China
  • 2Department of Gastrointestinal Surgery, The Second Xiangya Hospital, Central-South University, Changsha, Hunan, China
  • 3XiangYa School of Medicine, Central South University, Changsha, Hunan, China

A Corrigendum on
Role and mechanism of DNA methylation and its inhibitors in hepatic fibrosis

by Lyu S-Y, Xiao W, Cui G-Z, Yu C, Liu H, Lyu M, Kuang Q-Y, Xiao E-H and Luo Y-H (2023). Front. Genet. 14:1124330. doi: 10.3389/fgene.2023.1124330

In the published article, there was an error in the Funding statement. The statement neglected to mention the funding supported by the Fundamental Research Funds for the Central Universities of Central South University (2023ZZTS0880):

"This study was supported by the Natural Science Foundation of Hunan Province No.2021JJ30945 (to Y-HL) and Center for Medical Imaging in Hunan Province (2020SK4001)."

The correct Funding statement appears below.

"This study was supported by the Natural Science Foundation of Hunan Province No.2021JJ30945 (to Y-HL), Center for Medical Imaging in Hunan Province (2020SK4001) and the Fundamental Research Funds for the Central Universities of Central South University (2023ZZTS0880)."

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: hepatic fibrosis, DNA methylation, epigenetics, hepatic stellate cells (HSCs), DNA methylation inhibitors

Citation: Lyu S-Y, Xiao W, Cui G-Z, Yu C, Liu H, Lyu M, Kuang Q-Y, Xiao E-H and Luo Y-H (2023) Corrigendum: Role and mechanism of DNA methylation and its inhibitors in hepatic fibrosis. Front. Genet. 14:1265506. doi: 10.3389/fgene.2023.1265506

Received: 23 July 2023; Accepted: 28 July 2023;
Published: 11 August 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Lyu, Xiao, Cui, Yu, Liu, Lyu, Kuang, Xiao and Luo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Yong-Heng Luo, bHVveW9uZ2hlbmdAY3N1LmVkdS5jbg==

†These authors have contributed equally to this work and share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.